Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations

Human Molecular Genetics

Volumn 25, Issue 9, 2016, Pages 1875-1884

  Pan, Wenting ^a   Zhou, Liqing ^b   Ge, Minghua ^c   Zhang, Bin ^d   Yang, Xinyu ^a   Xiong, Xiangyu ^a   Fu, Guobin ^f   Zhang, Jian ^g   Nie, Xilin ^c   Li, Hongmin ^e   Tang, Xiaohu ^a   Wei, Jinyu ^a   Shao, Mingming ^e   Zheng, Jian ^e   Yuan, Qipeng ^a   Tan, Wen ^e   Wu, Chen ^e   Yang, Ming ^a,h   Lin, Dongxin ^e  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b Huaian No 2 Hospital   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

^e CANCER HOSPITAL   (China)

^f SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^g SHANDONG UNIVERSITY   (China)

^h SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DINUCLEOTIDE; G PROTEIN COUPLED RECEPTOR; LONG UNTRANSLATED RNA; C16ORF3 PROTEIN, HUMAN; LPAR4 PROTEIN, HUMAN; PURINERGIC P2 RECEPTOR; TUMOR PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GROWTH; CHINESE; CONTROLLED STUDY; EXOME; FEMALE; GENE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LPAR4 GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MIDDLE AGED; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; ONCOGENE; POINT MUTATION; POPULATION; PRIORITY JOURNAL; SANGER SEQUENCING; SOMATIC MUTATION; THYROID CARCINOMA; TUMOR SUPPRESSOR GENE; WILD TYPE; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; GENOTYPE; HIGH THROUGHPUT SEQUENCING; METABOLISM; MUTATION; PAPILLARY CARCINOMA; PATHOLOGY; PROCEDURES; PROGNOSIS; SECONDARY; THYROID GLAND; THYROID TUMOR;

CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; EXOME; FEMALE; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, PURINERGIC P2; RNA, LONG NONCODING; THYROID GLAND; THYROID NEOPLASMS;

EID: 84991328245     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw056     Document Type: Article

References (30)

1. Chen, W., Zheng, R., Zeng, H., Zhang, S. and He, J. (2015) Annual report on status of cancer in China, 2011. Chin. J. Cancer Res., 27, 2-12.
2. Schneider, A.B. and Sarne, D.H. (2005) Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat. Clin. Pract. Endocrinol. Metab., 1, 82-91.
3. Goldgar, D.E., Easton, D.F., Cannon-Albright, L.A. and Skolnick, M.H. (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst., 86, 1600-1608.
4. Cancer Genome Atlas Research Network. (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell, 159, 676-690.
5. Cibulskis, K., Lawrence, M.S., Carter, S.L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E.S. and Getz, G. (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol., 31, 213-219.
6. Lawrence, M.S., Stojanov, P., Polak, P., Kryukov, G.V., Cibulskis, K., Sivachenko, A., Carter, S.L., Stewart, C., Mermel, C.H., Roberts, S.A. et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 499, 214-218.
7. Lawrence, M.S., Stojanov, P., Mermel, C.H., Robinson, J.T., Garraway, L.A., Golub, T.R., Meyerson, M., Gabriel, S.B., Lander, E.S. and Getz, G. (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature, 505, 495-501.
8. Miller, C.A., White, B.S., Dees, N.D., Griffith, M., Welch, J.S., Griffith, O.L., Vij, R., Tomasson, M.H., Graubert, T.A., Walter, M.J. et al. (2014) SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput. Biol., 10, e1003665.
9. Lee, D.D. and Seung, H.S. (1999) Learning the parts of objects by non-negative matrix factorization. Nature, 401, 788-791.
10. Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Børresen-Dale, A.L. et al. (2013) Signatures of mutational processes in human cancer. Nature, 500, 415-421.
11. Waters, T.R. and Swann, P.F. (2000) Thymine-DNA glycosylase and G to A transition mutations at CpG sites. Mutat. Res., 462, 137-147.
12. Holderfield, M., Deuker, M.M., McCormick, F. and McMahon, M. (2014) Targeting RAF kinases for cancer therapy: BRAFmutated melanoma and beyond. Nat. Rev. Cancer, 14, 455-467.
13. Tang, C., Yang, L., Wang, N., Li, L., Xu, M., Chen, G.G. and Liu, Z.M. (2014) High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma. Int. J. Clin. Exp. Pathol., 7, 3213-3223.
14. Sharma, G.K., Dhillon, V.K., Masood, R. and Maceri, D.R. (2015) Overexpression of EphB4, EphrinB2, and epidermal growth factor receptor in papillary thyroid carcinoma: a pilot study. Head Neck, 37, 964-969.
15. Lam, A.K., Lau, K.K., Gopalan, V., Luk, J. and Lo, C.Y. (2011) Quantitative analysis of the expression of TGF-alpha and EGFR in papillary thyroid carcinoma: clinicopathological relevance. Pathology, 43, 40-47.
16. De Falco, V., Guarino, V., Malorni, L., Cirafici, A.M., Troglio, F., Erreni, M., Pelicci, G., Santoro, M. and Melillo, R.M. (2005) RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors. Oncogene, 24, 6303-6313.
17. Kunstman, J.W., Juhlin, C.C., Goh, G., Brown, T.C., Stenman, A., Healy, J.M., Rubinstein, J.C., Choi, M., Kiss, N., Nelson-Williams, C. et al. (2015) Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum. Mol. Genet., 24, 2318-2329.
18. Prensner, J.R. and Chinnaiyan, A.M. (2011) The emergence of lncRNAs in cancer biology. Cancer Discov., 1, 391-407.
19. Batista, P.J. and Chang, H.Y. (2013) Longnoncoding RNAs: cellular address codes in development and disease. Cell, 152, 1298-1307.
20. Hama, K., Aoki, J., Fukaya, M., Kishi, Y., Sakai, T., Suzuki, R., Ohta, H., Yamori, T., Watanabe, M., Chun, J. et al. (2004) Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem., 279, 17634-17639.
21. Lee, Z., Cheng, C.T., Zhang, H., Subler, M.A., Wu, J., Mukherjee, A., Windle, J.J., Chen, C.K. and Fang, X. (2008) Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol. Biol. Cell, 19, 5435-5445.
22. Matayoshi, S., Chiba, S., Lin, Y., Arakaki, K., Matsumoto, H., Nakanishi, T., Suzuki, M. and Kato, S. (2013) Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells. Int. J. Oncol., 42, 1560-1568.
23. Harper, K., Arsenault, D., Boulay-Jean, S., Lauzier, A., Lucien, F. and Dubois, C.M. (2010) Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation. Cancer Res., 70, 4634-4643.
24. Taghavi, P., Verhoeven, E., Jacobs, J.J., Lambooij, J.P., Stortelers, C., Tanger, E., Moolenaar, W.H. and van Lohuizen, M. (2008) In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation. Oncogene, 27, 6806-6816.
25. Lappano, R. and Maggiolini, M. (2011) G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov., 10, 47-60.
26. Wahlestedt, C. (2013) Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat. Rev. Drug Discov., 12, 433-446.
27. Wang, X., Li, M., Wang, Z., Han, S., Tang, X., Ge, Y., Zhou, L., Zhou, C., Yuan, Q. and Yang, M. (2015) Silencing of long noncoding RNAMALAT1 bymiR-101 andmiR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J. Biol. Chem., 290, 3925-3935.
28. Zhang, X., Zhou, L., Fu, G., Sun, F., Shi, J., Wei, J., Lu, C., Zhou, C., Yuan, Q. and Yang, M. (2014) The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer. Carcinogenesis, 35, 2062-2067.
29. Zhang, X., Wei, J., Zhou, L., Zhou, C., Shi, J., Yuan, Q., Yang, M. and Lin, D. (2013) A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma. Carcinogenesis, 34, 2309-2313.
30. Liu, L., Zhou, C., Zhou, L., Peng, L., Li, D., Zhang, X., Zhou, M., Kuang, P., Yuan, Q., Song, X. et al. (2012) Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer. Carcinogenesis, 33, 119-123.